{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:37Z","timestamp":1786120357881,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"DOI":"10.1097\/qai.0b013e3182423668","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T06:34:37Z","timestamp":1322634877000},"page":"274-280","source":"Crossref","is-referenced-by-count":38,"title":["Safety and Tolerability of Antiretroviral Therapy Among HIV-Infected Children And Adolescents In UGANDA"],"prefix":"10.1097","volume":"59","author":[{"given":"Vincent J.","family":"Tukei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Asiimwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Maganda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Atugonza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Sebuliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bakeera-Kitaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipa","family":"Musoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Kalyesubula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeodata","family":"Kekitiinwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1179\/146532810X12637745451915","article-title":". Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.","volume":"30","author":"Banerjee","year":"2010","journal-title":"Ann Trop Paediatr"},{"key":"R2-8-20210131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2334-10-109","article-title":". Lives saved by global fund-supported HIVAIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.","volume":"10","author":"Komatsu","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R3-8-20210131","first-page":"593","article-title":"Tanser F, et al..","volume":"24","author":"Ndirangu","year":"2010","journal-title":"Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact AIDS"},{"key":"R4-8-20210131","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1089\/aid.2009.0070","article-title":". Impact of highly active antiretroviral therapy (HAART) on AIDS and death in a cohort of vertically HIV type 1-infected children: 1980-2006.","volume":"25","author":"Palladino","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R5-8-20210131","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e318033ffa1","article-title":". Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.","volume":"44","author":"Forna","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-8-20210131","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1545109709343967","article-title":". Adverse drug reactions to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimen: a 24-week prospective study.","volume":"8","author":"Jena","year":"2009","journal-title":"J Int Assoc Physicians AIDS Care (Chic Ill)"},{"key":"R7-8-20210131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/aid.2007.0219","article-title":". Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.","volume":"24","author":"Laurent","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R8-8-20210131","first-page":"229","article-title":". Adverse effects of antiretroviral therapy for HIV infection.","volume":"170","author":"Montessori","year":"2004","journal-title":"CMAJ"},{"key":"R9-8-20210131","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1590\/S0100-879X2006000400010","article-title":". High incidence of adverse reactions to initial antiretroviral therapy in Brazil.","volume":"39","author":"Padua","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"R10-8-20210131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.trstmh.2009.07.009","article-title":". Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.","volume":"104","author":"Van Griensven","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R11-8-20210131","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/QAI.0b013e31821d33be","article-title":". Effect of specific ART drugs on lipid changes and the need for lipid management in children with HIV.","volume":"57","author":"Rhoads","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-8-20210131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/QAI.0b013e31822203f5","article-title":". Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C study.","volume":"57","author":"Jacobson","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-8-20210131","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1468-1293.2009.00750.x","article-title":". Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients.","volume":"11","author":"Cicconi","year":"2010","journal-title":"HIV Med"},{"key":"R14-8-20210131","first-page":"983","article-title":"Why do patients fail HIV therapyInt J Clin Pract.","volume":"61","author":"Waters","year":"2007","journal-title":""},{"key":"R15-8-20210131","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1089\/aid.2009.0274","article-title":". Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil.","volume":"26","author":"Cardoso","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R16-8-20210131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4314\/thrb.v11i1.43243","article-title":"HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania.","volume":"11","author":"Minzi","year":"2009","journal-title":"Tanzan J Health Res"},{"key":"R17-8-20210131","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00002030-200207050-00008","article-title":". The Senegalese governments highly active antiretroviral therapy initiative: an 18-month follow-up study.","volume":"16","author":"Laurent","year":"2002","journal-title":"AIDS"},{"key":"R18-8-20210131","doi-asserted-by":"crossref","first-page":"E1039","DOI":"10.1542\/peds.2009-1062","article-title":". Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children 5 years of age.","volume":"125","author":"Sauvageot","year":"2010","journal-title":"Pediatrics"},{"key":"R23-8-20210131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/tropej\/fmn080","article-title":". Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India.","volume":"55","author":"Kumarasamy","year":"2009","journal-title":"J Trop Pediatr"},{"key":"R24-8-20210131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinternmed.2009.432","article-title":". Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.","volume":"170","author":"Elzi","year":"2010","journal-title":"Arch Intern Med"},{"key":"R26-8-20210131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1310\/92VR-FP24-J8GA-B49Q","article-title":". Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients.","volume":"6","author":"Hawkins","year":"2005","journal-title":"HIV Clin Trials"},{"key":"R27-8-20210131","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.antiviral.2009.10.016","article-title":"Understanding and managing the adverse effects of antiretroviral therapy.","volume":"85","author":"Hawkins","year":"2010","journal-title":"Antiviral Res"},{"key":"R28-8-20210131","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2011.10-0519","article-title":". Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda.","volume":"84","author":"Masaisa","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"R29-8-20210131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1258\/095646204322764334","article-title":". Low serum vitamin B12 levels in an outpatient HIV-infected population.","volume":"15","author":"Hepburn","year":"2004","journal-title":"Int J STD AIDS"},{"key":"R30-8-20210131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V91.1.301","article-title":". Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project.","volume":"91","author":"Sullivan","year":"1998","journal-title":"Blood"},{"key":"R31-8-20210131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00042560-200104010-00003","article-title":"Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy.","volume":"26","author":"Semba","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-8-20210131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00042560-200201010-00007","article-title":"Anemia in HIV-infected patients receiving highly active antiretroviral therapy.","volume":"29","author":"Moore","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-8-20210131","first-page":"2","article-title":". Prevalence of anaemia and immunological markers among ghanaian HAART-naive HIV-patients and those on HAART.","volume":"11","author":"Owiredu","year":"2011","journal-title":"Afr Health Sci"},{"key":"R35-8-20210131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAI.0b013e318227b016","article-title":"Cardiovascular disease risk in pediatric HIV: the need for population-specific guidelines.","volume":"57","author":"Ross","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R36-8-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(09)62067-5","article-title":". Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.","volume":"375","author":"Mugyenyi","year":"2010","journal-title":"Lancet"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e3182423668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:25:59Z","timestamp":1786047959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201203010-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3182423668","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}